EVENT “BIOMARKERS AND SUBGROUPS” on FRIDAY JUNE 24
EFSPI/PSDM Meeting “Biomarkers and Subgroups”
Current trends in drug development are towards targeted therapies, aiming to offer optimal treatment options to patients. Biomarkers can be used to identify subgroups of patients who may respond differently to therapies. In this seminar, speakers from industry, academia and regulatory authorities address a number of relevant questions, and present case studies.
Speakers and Agenda
Confirmed speakers include Hans-Ulrich Burger (Roche), Norbert Benda (BfArM), Andrew Grieve (ICON), Tim Friede (University of Göttingen), Andrew Stone (independent consultant), Sebastian Jobjörnsson (Chalmers University) and Xavier Benain (Sanofi). Click here for the full agenda.
The presentations can be found at http://www.efspi.org/EFSPI/Events/Archive_Items/Biomarkers_and_Subgroups.aspx
The seminar was hosted by Astellas at their offices in Leiden, Netherlands.